2nd Quarter - Report

OGR for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

Firm
OGR
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General prescription drug affordability and access.

LobbyistCovered position, as disclosed
DEAN AGUILLEN —
MICHAEL DEE BUCHANAN New Chief of Staff, House Republican Conference; Chief of Staff/ Dep. Chief of Staff/ Legislative Director, Rep. Jeb Hensarling; Dir, Sen. Phil Gramm
CHRIS GIBLIN New Chief of Staff, Rep. John Carter; Legislative Director, Rep. Charlie Norwood
TIMOTHY MCGIVERN New Chief of Staff, Senator Sam Brownback
KARISSA WILLHITE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Provisions related to Part D access and drug pricing negotiation. Compulsory licensing policy issues. H.R.1046, Medicare Negotiation and Competitive Licensing Act of 2019. Proposed HHS Rule on Rebates.

LobbyistCovered position, as disclosed
DEAN AGUILLEN —
MICHAEL DEE BUCHANAN New Chief of Staff, House Republican Conference; Chief of Staff/ Dep. Chief of Staff/ Legislative Director, Rep. Jeb Hensarling; Dir, Sen. Phil Gramm
CHRIS GIBLIN New Chief of Staff, Rep. John Carter; Legislative Director, Rep. Charlie Norwood
TIMOTHY MCGIVERN New Chief of Staff, Senator Sam Brownback
KARISSA WILLHITE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1046 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.